Johnson & Johnson (JNJ) Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision

Johnson & Johnson (NYSE: JNJ) FY 2026 Other Release

Newsdesk: